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                            ABSTRACT 
 
Glutathione S Transferase catalyse the conjugation of glutathione with a wide mixed bag of 
hydrophobic mixes, for the most part bringing about nontoxic items that could be readily killed. 
As opposed to different organisms, the malarial parasite Plasmodium falciparum has one 
Glutathione S Transferase enzyme (Pfgst). This Glutathione S Transferase is highly found in 
the parasite, its movement was discovered to be increased in chloroquine cells, and it has been 
indicated to go about as a ligand in for parasitotoxic hemin. Thus, the enzyme speaks to a 
guaranteeing target for antimalarial drug development. The target is docked with small ligand 
molecules with AutoDock Vina. The ligand molecules are checked for their toxicity Pfgst has 
a shorter C-terminal area bringing about a more dissolvable-available binding site for the 
hydrophobic substrates. The ligand molecules selected for docking are used for the inhibition 
of the Glutathione S Transferase molecule. The ligands that are selected are chloroquine, S 
hexylglutathione, Artemesinin, Hemin, Protoporphyrin IX, Tetracycline, Quinidine and 
Quinine. The ligand molecules are found to inhibit the Glutathione S Transferase molecule in 
vivo. These findings thus suggest that above molecules can may be potentially used for the 
drug development of malaria.  
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                           CHAPTER 1                 
                       INTRODUCTION 
 
 
 
 
 
 
                                                  INTRODUCTION 
 
Malaria is a genuine illness that causes a high fever and chills. You can get it from a bite by a 
contaminated mosquito. Malaria is uncommon in the United States. It is frequently found in 
Africa, Southern Asia, Central America, and South America.  
Malaria is created by a bite from a mosquito contaminated with parasites. In exceptionally 
extraordinary cases, individuals can get malaria on the off chance that they come into contact 
with contaminated blood. A creating embryo may get the illness from its mother. You can't get 
malaria simply by being close to an individual who has the disease.  
Most malaria contaminations cause side effects like flu virus, for example, a high fever, chills, 
and muscle torment. Side effects have a tendency to travel every which way in cycles. A few 
types of malaria may cause more genuine issues, for example, damage to the heart, lungs, 
kidneys, or cerebrum. These types could be destructive.  
Glutathione S-transferases (GST) are a family of stage II detoxification enzymes catalysing the 
conjugation of glutathione (GSH) to an extensive assortment of electrophilic substrates [2]. 
The enzymes are rich in most living beings examined, going from prokaryotes to well evolved 
creatures [7]. The less toxic and more hydrophilic results of GST catalyzed responses could be 
in partially metabolized and discharged, accordingly ensuring cells against cytotoxic and gene 
toxic mixes [5]. Additionally conjugation responses, a few GST can catalyse GSH-dependent 
reduction of hydro peroxides produced, e.g., throughout oxidative stress. Notwithstanding their 
enzymatic capacities, GST can bind to an extensive variety of endogenous and exogenous 
ligands, for example, hormones and bilirubin and in addition drugs and pesticides, which 
regularly impair the catalytic action of the enzyme [3]. In the course of the most recent years 
GST research has concentrated on resistance phenomena in insect strains and multidrug-
resistant tumour cells. Because of their enzyme-specific overexpression in different tumours 
GST have developed as promising therapeutic targets, and a basis to use GST inhibitors in mix 
with alkylating executors to go around resistance has been built. A case for GST being included 
in resistance to insecticides are the DDT-metabolizing enzymes of the malaria vector 
Anopheles [1].  
Tropical malaria, which is created by the protozoan parasite Plasmodium falciparum, is 
answerable for ∼515 million clinical cases and one to three million deaths every year. The 
development and spread of drug resistance to normally utilized chemotherapeutics are main 
considerations contributing this expanding load [8].  
GST activity has been located in all Plasmodium species considered so far and additionally in 
all intra erythrocytic phases of the parasite [5]. Pfgst has been evaluated to speak to >1% of the 
aggregate cell protein. A part of GST from P. falciparum (Pfgst) in the advancement of drug 
resistance in malarial parasites has been proposed and is controversially examined [10]. The 
essential structure and additionally the three-dimensional X-beam structure of Pfgst vary 
essentially from human Gsts, and demonstrate that Pfgst can't be assigned to any of the 
previously known GST classes, subsequently speaking to a novel GST isoform. Since, besides, 
the parasite harbour one and only GST and inhibition of Pfgst is relied upon to aggravate GSH-
subordinate conjugation methods, to enhance levels of cytotoxic peroxides and to increase 
concentration of toxic ferriprotoporphyrin IX (FP), Pfgst is a most promising drug target [9].  
Identification of the area of ligand binding sites on a protein is of major importance for a reach 
of provisions including molecular docking, drug designing and structural identification and 
likewise helps in correlation of functional sites [6]. Now-a-days the improvement of 
bioinformatics is preparing for simple investigation of protein-ligand interaction. 
Computational biology and bioinformatics can possibly accelerate this methodology and 
likewise it helps in reducing the expense [4]. Docking is method which predicts the preferred 
orientation of one molecule to an alternate molecule when they are bound together to structure 
a stable complex molecule. Here two molecule bind to one another in a three dimensional 
space. Docking might be referred to as "lock and key" model. Here the protein can be a lock 
and the ligand might be called as key. There are different tools utilized for docking studies with 
the assistance of bioinformatics. Utilizing the bioinformatics tools time and expense of living 
work reduces definitely. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
                      CHAPTER 2 
             LITERATURE REVIEW 
            
 
 
 
 
        2.1 STRUCTURE OF GLUTATHIONE S TRANSFERASE 
 
     
   Figure 1.  Asymmetric structure of Glutathione S Transferase(1OKT)                                                           
  Figure 2. Assumed Biological molecule of Glutathione S Transferase(1OKT). 
 
 
                              2.2 NOVEL DRUG DISCOVERY STRATEGY 
 
          Drug discovery and advancement is exceedingly complex and, extensive and process. 
For another ligand to arrive at in the market as potential inhibitor must create by the 
methodology which is normally known as developmental chain or "pipeline: and comprises of 
various different stages. For the most part it might be assembled under two stages, early 
pharmaceutical exploration and late pharmaceutical R&D. Early pharmaceutical examination 
includes two steps prepare in which distinguishing proof and displaying of the biological target 
inside the body (the protein) is the first step, emulated by the second venture of ID of lead 
compound (ligand) that shows drug like properties concerning this protein. Later, the drug 
experiences numerous periods of clinical improvement in people. In the clinical stage, the drug 
is directed first to creatures and after that to human volunteers to focus:  
 
•         The channel of the drug through the body- beginning the time when it is controlled in   
body to the time when it is discharged from the body.  
•  Drug's impacts on the body.  
•  Its proficiency to cure the sickness being dealt with. 
•  Adverse reactions of the medication.  
      In silico drug design or CADD (Computer Aided Drug Design) system fills this 
examination prerequisite. Moreover, price water house coopers states that "the general expense 
of drug development could be decreased by to the extent that half through broad utilization of 
in silico innovations in drug discovery procedure". Also, studies from quantum mechanics, 
sub-atomic elements and sub-atomic dockings.  
 
     In silico drug finding methodology embody three stages: 
(i) First stage includes distinguishing proof of a helpful target and building a heterogeneous     
Little particle library to be tried against it, emulated by the improvement of a virtual  screening 
convention initialised by either docking of small particle from the library or building these 
structures in the active site by De novo design technique.  
(ii) In second stage, these selected hits are checked for specificity by docking at binding 
destinations of other known drug targets.  
(iii) In third stage, these selected hits are subjected to detail in silico ADMET profiling studies 
and those molecules that pass these studies are termed as leads. 
 
   2.3 DOCKING OF PROTEIN AND DRUG MOLECULES BY AUTODOCK TOOL 
 
  Auto Dock is widely used in the prediction of bimolecular complexes for structure & 
functional analysis and in molecular design. It combines an empirical free energy force field 
with a Lamarckian Genetic Algorithm (LGA), providing fast prediction of bound 
conformations with predicted free energies of association. 
Auto Dock was released in 1990 and consistently from early time it has proven to be an 
effective tool. It can predict accurately and quickly the bound conformation and binding 
energies of ligand with macromolecular targets. The primary algorithm used by Auto Dock for 
conformational searching is the Lamarckian Genetic Algorithm (LGA). The “Lamarckian” 
allows individual conformations to search their local conformational space, to find local 
minima, and ultimately pass this information to later generations. AutoDock4 is also 
incorporated with simulated annealing (SA) search method and a traditional genetic algorithm 
(GA) search method. It uses a semi empirical free energy force field to predict binding free 
energies of small molecules to macromolecular targets and shows a standard error of about 2-
3 kcal/mol in prediction of binding free energy in cross-validation studies. 
 
2.5 STUDY ON AVAILABLE SMALL LIGAND MOLECULES. 
ARTEMESININ 
                                              
Figure 3.Structure of Artemesinin from PubChem database. 
Artemesinin and its similar compounds are used widely all over the world because these 
compounds appear to be involve in heme-mediated decomposition of peroxide bridge to 
produce free radicals that are carbon centred. The involvement of heme explains the toxicity in 
the matter of malarial parasites. The resulting free radicals are alkylate hem end proteins, of 
which there are translationaly controlled tumour proteins. Clinically relevant artemesinin has 
not yet been demonstrated. 
 
CHLOROQUINE 
   
 
 
 
 
                                             
Figure 4. Structure of chloroquine from PubChem database. 
The uptake of chloroquine by Plasmodium Falciparum parasites has been attributed to specific 
carrier-mediated transport. Chloroquine is transported in the place of protons by the membrane 
of parasite Na+/H+ exchanger where it inhibits the polymerization of hemin, which allows the 
accumulation of toxic haemoglobin and kills the cell. 
 
HEMIN 
 
 
 
     
      
Figure 5. Structure of hemin from PubChem database. 
Malarial parasites that are isolated from the mouse erythrocytes are further lysed by hemin or 
by chloroquine-hemin complex amounts that could be produced by release of less than 0.1 
percent of the heme in the haemoglobin of the erythrocytes. This effect of hemin may explain 
the protection against malaria that is provided by thalassemia and various other conditions 
causing denaturation intracellular in haemoglobin. 
  
PROTOPORPHYRIN IX 
 
  
 
 
 
 
Figure 6. Structure of Protporphyrin IX from PubChem database 
The erythrocytes of Plasmodium Falciparum parasite converts most of the host haemoglobin 
heme into nontoxic crystal. This work examines a binding mechanism for zinc inhibition of 
heme crystallization which is similar to the quinolones that are antimalarial. Protoporphyrin IX 
never forms crystal only and never extends on already formed heme crystals. 
 
PYRIMETHAMINE 
 
 
 
 
Figure 7. Structure of Pyrimethamine from PubChem database. 
The trails that are therapeutic with Pyrimethamine have indicated that the drug could 
effectively control a clinical attack of vivax or other malarial infection. In two or three days 
but it might fail in certain percentage of Plasmodium falciparum infection. 
 
QUININE 
                                                                      
Figure 8. Structure of Quinine from PubChem database. 
Quinine and the other derivative drugs are effective treatments for severe falciparum malaria. 
Trails have not demonstrated convincing evidence of a mortality advantage for quinine. These 
results can be probably generalised to the treatment of severe malaria in adults from all areas 
especially in those areas that with the hyperparasitemia.  
 
TETRACYCLINE 
                                                    
 
Figure 9. Structure of Tetracycline from PubChem database.    
Tetracyclines are very effective but they are slow-acting antimalarial drugs whose mechanism 
of action remains uncertain. To characterize the mechanism of tetracycline, we evaluated their 
activities, impacts on parasite transcription, and its effects on two targets, apicoplast and the 
mitochondria, in cultured Plasmodium falciparum. 
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MATERIALS AND METHODS 
 
3.1 SOFTWARES USED 
 
3.1.1 Pubchem 
3.1.2 NCBI 
3.1.3 Swissmodel.exapsy.org 
3.1.4 PubMed 
3.1.5 PDB (rcsb.pdb.org) 
3.1.6 Chimera 
3.1.7 MGL Tools 
3.1.8 Auto Dock Tools 
3.1.9 Auto Dock Vina 
3.1.10 Swiss PDB Viewer 
3.1.11 Toxicity Bio server 
3.1.12 CastP server 
 
 
3.2 PROTOCOL FOLLOWED 
 
3.2.1   Inhibition of Glutathione S Transferase 
 
 
 
                       Retrieval of 3D structure of 1OKT protein from PDB  
   
                                                                  
                     Collection of small ligand compounds from Pubchem database 
                                                                   
             Conversion of all the ligand 3-D compounds from .sdf format to .pdb format 
                                                                   
        Conversion of ligands and protein into .pdbqt file format by Auto Dock Tools 
                                                                   
        Docking of all the ligand compounds with Glutathione S Transferase by Auto Dock Vina 
                                                                   
        Analysis of binding energy and site of binding from docking by chimera 
                                                                   
                   Saving the output in .pdbqt format for further viewing 
                                                                   
                      Energy minimisation of the result in Swiss pdb viewer 
                                                                    
                             Toxicity review using toxicity bio server 
                                                                      
                                Analysis of 2D structure using ligplot+ 
 
 
 
3.3 METHODOLOGY 
             PDB (protein data bank) provides us with the 3-dimentional structural data of 
macromolecules such as proteins and nucleic acids. This was founded in Brookhaven National 
Laboratories (BNL). This is of much importance because the understanding of the structure of 
the compounds is the basic step.   
            
             The Glutathione S transferase protein with the PDB ID 1OKT was downloaded 
 
 
 Figure10. Homepage of PDB database where 1OKT was downloaded. 
 
3.3.1 Retrieval of small ligand molecules from PubChem database 
 
PubChem is a database which provides us with structures of small organic molecules. It also 
contains information related to its origin and related literatures. It is updated by NCBI. 
Compounds are freely downloaded in .sdf file format or chemical (CID) format. 
 a) The URL for the site is pubchem.ncbi.nlm.nih.gov. 
b) In the search box name of the inhibitors was typed. 
c) The 3-D structures was retrieved in .sdf file format. 
 
 3.3.2 Conversion of all the ligand 3-D compounds from .sdf format to .pdb format 
 UCSF Chimera (or simply Chimera) is an extensible program for interactive   
visualization and analysis of molecular structures and related data, including density maps, 
assemblies, sequence alignments, docking results, trajectories, and conformational ensembles. 
a) Click on “File” and then “open” and browse for ligand molecule. 
b) Now convert it to .pdb by click “Save as .pdb”. 
 
3.3.3Conversion of ligands and protein into .pdbqt file format by Auto Dock Tools. 
Auto Dock is currently maintained by The Scripps Research Institute and Olson Laboratory. 
a) Select the protein molecule in Autodock tools by clicking on ”File” and “Open” 
b) Click on “Edit” and remove Water molecules. 
c) Click on “Edit” and polar hydrogen molecules only. 
d) Now click on “File” and “Write PDBQT” and save. 
e) Now select small ligand molecule by clicking on “Ligand” and “Open” 
f) Click on Ligand and “Choose Root” 
g) Click on Ligand and “Detect Root” 
h) Now clicking on File and “Write PDBQT” it is saved. 
i) All the files are kept in one folder for further use. 
 
3.3.4 Docking of all the ligand compounds with Glutathione S Transferase by Auto Dock 
Vina 
Auto Dock Vina is a software used for the process of docking of the protein molecule with the 
small ligand molecules. The molecules which are already prepared by using the MGL tools are 
taken and they are docked using this software. The coordinates of the active site predicted as 
Tyrosine at the position of 9 of the chain are given. The target is docked at this site with the 
small ligand molecules using Auto Dock Vina. 
 3.3.5 Toxicity Prediction by Chem Bio server 
This is a Server which is part of the Bio academy Bio server that contains some tools and web 
services developed in the Biomedical Research Foundation of the Academy of Athens.  
Its main aim is to improve computational molecule screening and analysis and it is financed by 
the Greek Ministry of Education Cooperation Proposal Entitled as PIK3CA Oncogenic 
Mutations in Breast and Colon Cancers. 
a) The ligand molecule in either .mol or .sdf format is uploaded 
b) Then on clicking “Process Data” at the end of the page, it gives the result whether the 
compound is toxic or nontoxic. 
c) If the compound is toxic, it shows because of which molecule. 
 
 
Figure 11. Homepage of Toxicity Bio server online. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
                 CHAPTER 4 
   RESULTS AND DISCUSSION 
       
  
 
 
 
 
 
 
 
 
                                                 4.1 RESULT 
When present as a trophosite in human erythrocytes, the malarial parasite Plasmodium 
Falciparum exhibits an intense glutathione metabolism. Glutathione plays a role not only in 
anti-oxidative defence and in maintaining the reducing environment of cytosol. Many of the 
known glutathione dependent processes are directly related to the specific lifestyle of the 
parasite. Reduced glutathione supports rapid cell growth by providing electrons for de 
oxyribose nucleotide synthesis and takes part in detoxifying heme, a product of haemoglobin 
digestion. Cibacron Blue, an inhibitor of the structurally known P. falciparum Glutathione 
reductase, appears to be a promising antimalarial medication when given in combination with 
chloroquine. 
Inhibitory compounds were selected which were already reported to inhibit the Glutathione S 
Transferase protein in vivo. The compounds selected were artemesinin, chloroquine, cibacron 
blue, hemin, protoporphyrin IX, pyrimethamine, quinidine, quinine, S hexylglutathione and 
tetracycline. 
To identify the binding sites of glutathione s transferase, a server castP was used and the 
binding site of Tyrosine (TYR) at the position 9 of the chain B is selected. 
The docking is done with the Autodock Vina tool and results were observed. 
The result of docking with ligand molecule Artemesinin 
 
Table 1 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1        -12.0      0.000      0.000 
   2        -11.9      1.770      3.397 
   3        -11.5      1.461      3.582 
   4        -11.5      1.673      2.889 
   5        -11.4      1.600      2.543 
   6        -11.2      1.525      3.241 
   7        -11.1     11.599     12.585 
   8        -11.1     11.532     12.457 
   9        -11.1      1.044      2.781 
  
 
The result of docking with ligand molecule chloroquine. 
Table 2 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -8.6      0.000      0.000 
   2         -8.4      1.213      2.098 
   3         -8.2      1.802      2.255 
   4         -7.7     12.998     13.938 
   5         -7.7     14.043     15.826 
   6         -7.7      1.681      3.093 
   7         -7.5     15.583     17.355 
   8         -7.5     14.973     16.645 
   9         -7.5      3.009      6.947 
 
The result of docking with the ligand molecule cibacron blue. 
Table 3 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1        -12.5      0.000      0.000 
   2        -12.4     22.408     25.043 
   3        -12.4      3.396      8.186 
   4        -12.2      2.566      4.430 
   5        -12.0     19.580     23.312 
   6        -11.9      2.415      4.072 
   7        -11.8     20.066     23.020 
   8        -11.8     23.613     26.540 
   9        -11.7     23.574     26.636 
 
 
The result of docking with the ligand molecule hemin 
Table 4 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -9.4      0.000      0.000 
   2         -9.4      3.161      5.170 
   3         -9.3     18.643     21.529 
   4         -9.3      3.431      6.919 
   5         -9.2     19.052     21.927 
   6         -9.2      3.091      6.846 
   7         -9.2      3.185      5.405 
   8         -9.2      0.530      4.269 
   9         -9.1      2.547      4.597 
The result of docking with the ligand molecule protoporphyrin IX 
Table 5 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -9.2      0.000      0.000 
   2         -9.1      3.176      5.255 
   3         -8.9      3.436      7.066 
   4         -8.9     18.434     21.465 
   5         -8.9      0.623      4.367 
   6         -8.9     18.848     21.916 
   7         -8.9      3.115      6.996 
   8         -8.9      3.183      5.477 
   9         -8.8      2.078      4.815 
 
 
 
The result of docking with the ligand molecule pyrimethamine. 
Table 6 
 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -8.6      0.000      0.000 
   2         -8.2      2.397      2.924 
   3         -7.9      2.763      4.381 
   4         -7.6     11.620     12.545 
   5         -7.6     14.687     15.384 
   6         -7.5     12.651     13.507 
   7         -7.5     15.802     16.619 
   8         -7.4     11.888     12.796 
   9         -7.3     18.052     19.187 
 
 
The result of docking with the ligand molecule quinidine. 
Table 7 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -4.1      0.000      0.000 
   2         -4.0     19.885     20.080 
   3         -3.7     23.606     23.963 
   4         -3.5     17.035     17.234 
   5         -3.5     13.298     13.755 
   6         -3.5     11.208     11.453 
   7         -3.4     14.870     15.049 
   8         -3.4     17.557     17.829 
   9         -3.4     23.387     23.806 
 
 
 
The result of docking with the ligand molecule quinine. 
Table 8 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -9.3      0.000      0.000 
   2         -8.8      1.101      2.188 
   3         -8.8      1.389      2.334 
   4         -8.7      2.031      5.651 
   5         -8.1      9.891     12.562 
   6         -8.1      1.854      5.789 
   7         -8.0      9.754     12.580 
   8         -8.0     10.382     12.068 
   9         -7.8      9.654     11.720 
 
 
 
The result of docking with the ligand molecule S hexylglutathione. 
Table 9 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1         -8.6      0.000      0.000 
   2         -8.4     13.009     14.418 
   3         -8.2      2.244      6.222 
   4         -7.8      2.837      6.390 
   5         -7.7     11.875     13.908 
   6         -7.3     12.129     13.686 
   7         -7.1     11.778     13.184 
   8         -7.0     13.137     13.831 
   9         -6.9     13.018     14.754 
 
 
 
 
The result of docking with the ligand molecule tetracycline. 
Table 10 
Mode |   affinity | dist from best mode 
     | (kcal/mol) | rmsd l.b.| rmsd u.b. 
-----+------------+----------+---------- 
   1        -11.1      0.000      0.000 
   2        -11.0     19.342     20.173 
   3        -10.8     19.280     20.016 
   4        -10.5     18.911     19.552 
   5        -10.4     20.721     21.150 
   6        -10.2     19.445     21.184 
   7        -10.2     19.605     20.672 
   8        -10.0      2.186      5.974 
   9        -10.0     18.979     19.765 
 
 
 The docking is done with various small ligand molecules which are similar in structure with 
the already available drugs and the results were noted  
Table 11 
Figure 12. Structures of the small ligand molecules used for Docking. 
Serial 
num. 
PubChem ID  Structure of the ligand molecule  Affinity 
(Kcal/mol
) 
 
1 Artemesinine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-11.3 
2 Chloroquine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-5.2 
3 AGN-PC-0CQS90 
 
-16.4 
4 AGN-PC-001O39 
 
-9.9 
5 SureCN3819053 
 
-9.4 
6 Pyrimethamine-d3 
 
-8.3 
7 Quinidine-d3 
 
-9.6 
8 Hexylglutathione 
 
-8.7 
9 Tetracycline 
 
-17.4 
 
 
 
TOXICITY PREDICTION 
 
It is needed for early detection  
a) Increasing the cost for drug discovery 
b)  The need for focussing resources on drug leads and candidates likely to be safe to 
patient 
Toxicity is a major contributor to high attrition rates of new chemical entities in drug 
discoveries. In this study, an order classifier was built to predict the series of toxic effects based 
on data concerning chemical-chemical interactions. 
 Table 12 
 
     Serial number Pubchem ID   Toxicity 
 
1 CID_68827 Non toxic 
 CID_71676106 Non toxic 
 CID_73265315 Non toxic 
2 CID_64927 Non toxic 
 CID_83818 Non toxic 
 CID_91441 Non toxic 
 CID_149423 Non toxic 
3 CID_44285647 Toxic  
 CID_44456324 Toxic  
 CID_59102333 Toxic  
4 CID_50921549 Non toxic 
 CID_73152295 Non toxic 
 CID_73152296 Non toxic 
5 CID_59475470 Non toxic 
 CID_68801257 Non toxic 
 CID_71695767 Non toxic 
6 CID_134531 Non toxic 
 CID_23423607 Non toxic 
 CID_45040307 Non toxic 
7 CID_59091406 Non toxic 
 CID_68007244 Non toxic 
 CID_71751934 Non toxic 
8 CID_5141 Non toxic 
 CID_14389509 Non toxic 
 CID_200556241 Non toxic 
9 CID_160964102 Toxic  
 CID_162173265 Toxic 
 CID_165280009 Toxic 
 
 
4.2 RESULT DISCUSSION: 
 
The docking of the ligands was carefully observed and their interactions and orientations were 
also monitored. The results show that NCGC001161634-07 having a highest binding affinity 
of -11.3 Kcal/mol, second is the AGN-PC-001039 with binding affinity of -9.9 Kcal/mol and 
then Quinidine-d3 with binding affinity of -9.6 Kcal/mol. All the ligand molecules with high 
binding affinity than the ATP molecule, which was kept as control to row down the molecules. 
Hence these molecules which are nontoxic and having a high binding affinity can be used as 
glutathione s transferase inhibitors.  
   
The ligand molecules which are having a higher binding affinity than the molecules of 
artemesinin and quinidine cannot be used as the potential inhibitors of glutathione s transferase 
as they are found to be toxic in nature. 
 
The result of the docked molecules are shown below 
 Figure 13. AGN-PC-001039 docking result in Python Molecule Viewer. 
 Figure 14. Quinidine-d3 docking result in python molecule viewer. 
 
 Figure 15. NCGC001161634-07 result in Python Molecule Viewer. 
 
 
 
4.3 CONCLUSION: 
 
In the current study we found out that the small ligand molecules that are used for the process 
of docking are bound to the Glutathione S Transferase in the vicinity of the Tyrosine region. 
Glutathione S Transferase is a promising drug target for the inhibition of the malarial disease. 
The small ligand molecules like S Hexylglutathione, Quinine, Pyrimethamine, Tetracycline, 
Protoporphyrin IX and Cibacron Blue revealed strong binding but with less docking score. The 
in silico docking study validates inhibitory activity of Glutathione S Transferase with 
molecules like AGN-PC-001O39, Quinidine-d3 and NCGC001161634-07. Hence these 
compounds are novel and alternate drug therapy for the treatment of malaria through the 
inhibition of Glutathione S Transferase. Further studies are required to mark them as 
compounds for the development of drugs against malaria. 
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